Bixiye
QP95-18 Provider Cost Data Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018
Natiijooyinka Raadinta
Soo bandhiga 3111 - 3120 ee natiijooyinka 4919
Bixiye
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 28, 2018
Bixiye
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP70-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3) and Lanoxin (digoxin) Injection for Minnesota Health Care Programs Subscribers
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Bixiye
QP35-17 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo Barnaamijka: Nov 07, 2017
Bixiye
QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA)
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2018
Bixiye
QP99-18 New FEP Employee Opioid Prescription Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018
Bixiye
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Bixiye
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Taariikhda dhaqangalka Barnaamijka: Jul 20, 2017
Bixiye
QP20-17 Searching Eligibility and Benefits
Taariikhda barnaamijka Dhaqangalayso Agosto 08, 2017